The role of breast MRI in newly diagnosed breast cancer: An evidence-based review
| Autor: | G. Paul Wright, Jessica Thompson |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment Breast Neoplasms Disease Newly diagnosed 030218 nuclear medicine & medical imaging 03 medical and health sciences 0302 clinical medicine Breast cancer Humans Medicine Breast MRI Chemotherapy medicine.diagnostic_test business.industry General Medicine Evidence based review medicine.disease Magnetic Resonance Imaging 030220 oncology & carcinogenesis Cohort Female Surgery Radiology business Mastectomy |
| Zdroj: | The American Journal of Surgery. 221:525-528 |
| ISSN: | 0002-9610 |
| DOI: | 10.1016/j.amjsurg.2020.12.018 |
| Popis: | The utility of pre-operative MRI in patients with newly diagnosed invasive breast cancer remains a topic of debate. Those who advocate for pre-treatment imaging contend that MRI may detect additional disease not otherwise appreciated on conventional imaging and may provide more accurate staging information to guide treatment. Additionally, it has been proposed that MRI can be utilized to assess extent of residual disease in patients undergoing neoadjuvant chemotherapy. Conversely, those in opposition maintain that routine pre-operative MRI subjects patients to unnecessary ipsilateral mastectomies and prophylactic contralateral mastectomies with no difference in oncologic outcome. When stratified based on tumor biology and patient characteristics, the data suggests that pre-treatment MRI may be advantageous in certain subsets when compared to the general cohort of breast cancer patients. This review recapitulates the current literature on the impact of breast MRI on the surgical management and outcomes of newly diagnosed breast cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect